Arcus Biosciences, Inc. (RCUS) Social Stream



Arcus Biosciences, Inc. (RCUS): $15.42

0.31 (+2.05%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add RCUS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#61 of 339

in industry

ARCUS BIOSCIENCES INC (RCUS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ARCUS BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $70 $50 $59.833 $17.73 237.47%
2021-11-17 8 $70 $48 $58.142 $17.73 227.93%
2021-11-18 8 $100 $48 $62.714 $17.73 253.72%
2021-11-22 9 $100 $48 $64.857 $17.73 265.8%
2022-02-24 7 $100.001 $53 $67 $17.73 277.89%
2022-04-12 7 $100.001 $53 $68 $17.73 283.53%
2022-05-10 7 $77 $53 $63.143 $17.73 256.14%
2022-05-13 7 $77 $42 $59.571 $17.73 235.99%
2022-07-08 7 $66 $42 $55.714 $17.73 214.24%
2022-08-04 7 $60 $36 $50.428 $17.73 184.42%
2022-08-18 7 $60 $36 $48.571 $17.73 173.95%
2022-08-31 8 $60 $36 $48.875 $17.73 175.66%
2022-10-11 9 $60 $36 $47.875 $17.73 170.02%
2022-10-14 8 $60 $36 $45.285 $17.73 155.41%
2022-11-03 7 $60 $36 $45.125 $17.73 154.51%
2022-11-18 8 $51 $33 $41.75 $17.73 135.48%
2022-11-23 9 $51 $33 $41.375 $17.73 133.36%
2022-12-20 9 $51 $24 $40.875 $17.73 130.54%
2022-12-22 9 $51 $36 $42.375 $17.73 139%
2023-01-09 9 $51 $36 $42.375 $17.73 139%
2023-03-01 9 $51 $24 $40.875 $17.73 130.54%
2023-03-02 9 $51 $23 $40.75 $17.73 129.84%
2023-05-10 9 $51 $23 $40.5 $17.73 128.43%
2023-05-15 9 $51 $22 $40.375 $17.73 127.72%
2023-08-08 9 $51 $22 $40.5 $17.73 128.43%
2023-08-21 9 $51 $21 $40.125 $17.73 126.31%
2023-08-23 10 $70 $21 $43.444 $17.73 145.03%
2023-08-24 10 $70 $21 $43.777 $17.73 146.91%
2023-11-07 10 $70 $23 $44 $17.73 148.17%
2023-11-08 10 $70 $23 $42.888 $17.73 141.9%
2023-11-13 10 $70 $23 $42.555 $17.73 140.02%

The Trend in the Analyst Price Target


RCUS's average price target has moved up $4.56 over the prior 42 months.

RCUS reports an average of 128.44% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 9 51 24 40.875 23.09 77.02%
2023-06-02 9 51 22 40.500 21.01 92.77%
2023-10-24 10 70 23 44.000 15.87 177.25%
2023-11-07 10 70 23 44.000 16.45 167.48%
2023-11-13 10 70 23 42.555 13.43 216.87%

RCUS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 9 0 1 0 0 10

The Trend in the Broker Recommendations


RCUS's average broker recommendation rating improved by 0.02 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, ARCUS BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 3528.02% of them.
  • RCUS has a lower variance in analysts' estimates than -2669.84% of all US stocks.
  • ARCUS BIOSCIENCES INC's average analyst price target is greater than 2813.6% of Pharmaceutical Products stocks.
  • In terms of how ARCUS BIOSCIENCES INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 2271.54% of that group.

In the Pharmaceutical Products industry, ZYME, HCM, and ORGO are the three stocks most similar to ARCUS BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding RCUS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!